Rivastigmine Teva 4.6mg / 24h Transdermal Patches

Licence status
Withdrawn: 01/02/2018
Active substances
Rivastigmine base
Dosage Form
Transdermal patch
Licence number
PA0749/203/001
Licence holder
Teva Pharma B.V.

Product documents

Licence information

ATC code
N06DA Anticholinesterases, N06DA03 rivastigmine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/08/2013